α-Tocopheryl Succinate Induces Apoptosis in Prostate Cancer Cells in Part through Inhibition of Bcl-xL/Bcl-2 Function
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Although the antitumor effect of alpha-tocopheryl succinate (vitamin E succinate) has been well demonstrated, its underlying mechanism remains elusive. This study provides evidence that inhibition of Bcl-xL/Bcl-2 function represents a major pathway whereby alpha-tocopheryl succinate mediates apoptosis induction in prostate cancer cells. In vitro data indicate that alpha-tocopheryl succinate was able to disrupt the binding of Bak BH3 peptide to Bcl-xL and Bcl-2 with IC50 of 26 microm, in line with its potency in antiproliferation. Treatment of PC-3 cells with this agent led to reduced association of Bcl-2 and Bcl-xL with Bak, leading to caspase-dependent apoptosis. Moreover, overexpression of Bcl-xL protected LNCaP cells from the apoptosis induction. This mechanistic finding provided a basis to develop potent Bcl-xL/Bcl-2 inhibitors. Docking of alpha-tocopheryl succinate into the Bak peptide-binding site indicates that it adopted a unique hairpin-shaped conformation for protein interactions. We rationalized that the hemisuccinate and the two proximal isopranyl units of the side chain played a crucial role in ligand anchoring and protein-ligand complex stabilization, respectively. However, exposure of the distal isopranyl unit to a polar environment might diminish the binding affinity of alpha-tocopheryl succinate. This premise was corroborated by a structure-activity analysis of a series of derivatives with truncated side chains and/or altered carboxyl terminus. This computer model predicted that the removal of the distal isopranyl unit from the side chain would improve binding affinity, leading to two agents with significantly higher potency in inhibiting Bak peptide binding and in suppressing prostate cancer cell proliferation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the CI inhibitor rotenone destabilizes microtubules, 40,41 and the CII inhibitor α-TOS as well as the complex III inhibitor antimycin act as BH3 mimetics.42,43”
From Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation (2015) · cites this paper as [43]
Citations
Cites
Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges
Gasteiger, J., & Marsili, M. (1980) · Tetrahedron · doi:10.1016/0040-4020(80)80168-2 · Cited by 4,157
Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis
Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., et al. (1997) · Science · doi:10.1126/science.275.5302.983 · Cited by 1,476
Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL
Degterev, A., Lugovskoy, A., Cardone, M., Mulley, B., Wagner, G., Mitchison, T., & Yuan, J. (2001) · Nature Cell Biology · doi:10.1038/35055085 · Cited by 550
Selective cancer cell killing by α-tocopheryl succinate
Neuzil, J., Weber, T., Gellert, N., & Weber, C. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1559 · Cited by 240
Shiau, C.-W., Yang, C.-C., Kulp, S. K., Chen, K.-F., Chen, C.-S., Huang, J.-W., & Chen, C.-S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1677 · Cited by 222
Self-citationα-Tocopheryl Succinate, the Most Effective Form of Vitamin E for Adjuvant Cancer Treatment: A Review
Prasad, K. N., Kumar, B., Yan, X.-D., Hanson, A. J., & Cole, W. C. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719283 · Cited by 208
Weber, T., Lu, M., Anděra, L., Lahm, H., Gellert, N., Fariss, M. W., Kořínek, V., Sattler, W., Ucker, D. S., Terman, A., et al. (2002) · PubMed · Cited by 203
Prasad, K. N., & Edwards‐Prasad, J. (1982) · PubMed · Cited by 193
Weber, T., Dalen, H., Andera, L., Nègre-Salvayre, A., Augé, N., Sticha, M., Lloret, A., Terman, A., Witting, P. K., Higuchi, M., et al. (2003) · Biochemistry · doi:10.1021/bi020527j · Cited by 170
Vitamin E Succinate Promotes Breast Cancer Tumor Dormancy
Malafa, M. P., & Neitzel, L. T. (2000) · Journal of Surgical Research · doi:10.1006/jsre.2000.5948 · Cited by 154
Research works printed but not linked: 5
- Prasad, 1982, Cancer Res., 42, 550
- Weber, 2002, Clin. Cancer Res., 8, 863
- Turley, 1997, Cancer Res., 57, 2668
- Yu, 2001, Cancer Res., 61, 6569
- Li, 2001, Cancer Res., 61, 1699
Cited by
Items 101–112 of 112
Mitocans, Mitochondria-Targeting Anticancer Drugs
Neužil, J., Dong, L., & Rohlena, J. (2012) · Oxidative stress and disease · doi:10.1201/b12308-6 · Cited by 1
Metabolic engineering via the chloroplast genome
Ruhlman, T. A., & Daniell, H. (2007) · Cited by 1
Li, J. (2006) · Texas ScholarWorks (Texas Digital Library)
Chemoprevention of Prostate Cancer: Agents, Studies and Future Prospects
Yafi, F. A., Aprikian, A. G., & Kassouf, W. (2008) · Aging Health · doi:10.2217/1745509x.4.5.469
Hill, C. U. F. K. (2015) · Figshare
Pasdar, E. A. (2015) · Griffith Research Online · doi:10.25904/1912/352
Novel Treatment of Breast and Prostate Cancer, and Mesothelioma by Targeting Cancer Stem Cells
Zobalová, R. (2013) · Griffith Research Online · doi:10.25904/1912/1607
Ni, J., Mai, T., Pang, S., Haque, I., Huang, K., DiMaggio, M. A., Xie, S., James, N. S., Kasi, D., Chemler, S. R., et al. (2023) · doi:10.1158/1078-0432.c.6517461.v1
KARTIKA, I. R., Ernawati, T., Jusman, S. W. A., & Sadikin, M. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2024v16i3.50040
Marotta, C., Cirri, D., Maimone, M. C., Giacomelli, C., Trincavelli, M. L., Salassa, L., Gabbiani, C., & Pratesi, A. (2025) · Dalton Transactions · doi:10.1039/d5dt01603g
Metadata
- Authors
- Shiau, C.-W., Huang, J.-W., Wang, D.-S., Weng, J.-R., Yang, C.-C., Lin, C.-H., Li, C., & Chen, C.-S.
- Affiliations
- The Ohio State University (US)
- China Medical University (TW)
- Corresponding author
- Chen, Ching-Shih
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-04
- Volume
- 281
- Issue
- 17
- Pages
- 11819-11825
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2129211064
- Cited by
- 113
- References
- 25
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 6 · 2017: 2 · 2016: 6 · 2015: 5 · 2014: 6 · 2013: 4 · 2012: 8
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5296 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 112250, R01CA112250)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Keywords
- alpha-tocopheryl succinate, vitamin E succinate, prostate cancer, apoptosis, Bcl-xL, Bcl-2, caspase-dependent apoptosis, structure-activity relationship, molecular docking, structure-activity analysis, PC-3 cells, LNCaP cells
- MeSH terms
- Humans, Male, Models, Molecular, Prostatic Neoplasms, Tumor Cells, Cultured, Vitamin E, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Tocopherols, RNA, Small Interfering, Cytochromes c, Cell Proliferation, bcl-X Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.